Compare Cronos Group Inc (CRON) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Meta Platforms Inc — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while Meta Platforms Inc trades at $599.1 (market cap $1.52T). The key difference: Meta Platforms Inc is far larger — about 1369.4× Cronos Group Inc's market cap, and Meta Platforms Inc pays a 0.35% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | META | |
|---|---|---|
Market Cap | $1.11B | $1.52T |
Sector | Health | Media |
52-Week High | $3.27 | $790.00 |
52-Week Low | $2.30 | $525.72 |
Enterprise Value | $310.67M | $1.54T |
Volume | — | 24,093,972 |
Dividend Yield | — | 0.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
META stock trades at $594.92, up 0.48% over 24 hours, with a bearish technical signal driven by moving averages and overbought short-term RSI. The company reported strong Q1 2026 earnings of $10.44 EPS, beating expectations, but missed in Q2 2026. Revenue growth remains robust, with 2025 revenue at $200.97 billion, though net income dipped to $60.46 billion. Recent news highlights the launch of AI model Muse Spark and a legal ruling in Massachusetts over youth addiction claims.
Outlook is mixed: analyst consensus is bullish with a $761.95 price target, citing AI innovations and solid fundamentals, but risks include high capital expenditure, regulatory lawsuits, and competitive pressures. The stock's valuation metrics like P/E of 22.41 suggest room for growth if execution continues, but investors should weigh legal and market volatility concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
